Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Mirena levonorgestrel system.

C Jay McGavigan1, Iain T Cameron

  • 1Department of Obstetrics and Gynecology, Southern General Hospital, South Glasgow University Hospitals NHS Trust, Govan, Glasgow, UK.

Drugs of Today (Barcelona, Spain : 1998)
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Dilated Thin-Walled Blood and Lymphatic Vessels in Human Endometrium: A Potential Role for VEGF-D in Progestin-Induced Break-Through Bleeding.

PloS one·2021
Same author

Access to and sustainability of abortion services: a systematic review and meta-analysis for the National Institute of Health and Care Excellence-new clinical guidelines for England.

Human reproduction update·2020
Same author

Cyclical progestogens for heavy menstrual bleeding.

The Cochrane database of systematic reviews·2019
Same author

Abnormal uterine bleeding.

British medical bulletin·2019
Same author

Abnormal uterine bleeding.

British medical bulletin·2017
Same author

Prescribing safety: ensuring that new graduates are prepared.

Lancet (London, England)·2015

The levonorgestrel intrauterine system (IUS) is a safe and effective long-term contraceptive. While it reduces menstrual blood loss, counseling on initial breakthrough bleeding is vital for patient adherence.

Area of Science:

  • Gynecology
  • Reproductive Medicine
  • Pharmacology

Background:

  • The levonorgestrel intrauterine system (IUS) is a widely used long-term contraceptive.
  • It offers benefits beyond contraception, including reduced menstrual blood loss.
  • Potential applications exist for benign gynecological disorders and hormone replacement therapy.

Purpose of the Study:

  • To review the safety, efficacy, and side effect profile of the levonorgestrel IUS.
  • To discuss its role in managing heavy menstrual bleeding and other gynecological conditions.
  • To highlight the importance of patient counseling regarding breakthrough bleeding.

Main Methods:

  • Literature review of studies on levonorgestrel IUS.
  • Analysis of clinical data regarding contraceptive efficacy and side effects.

Related Experiment Videos

  • Evaluation of therapeutic applications in gynecology.

    • Main Results:

    • The levonorgestrel IUS is a safe and effective long-term contraceptive.
    • Significant reduction in menstrual blood volume observed in users.
    • Breakthrough bleeding in early use is a common side effect, potentially linked to endometrial vascular effects.

    Conclusions:

    • The levonorgestrel IUS is a valuable tool for contraception and managing heavy menstrual bleeding.
    • Understanding and counseling on breakthrough bleeding are essential for optimal patient compliance.
    • Further research into the mechanism of breakthrough bleeding may refine its use.